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Asthma and depression: A pragmatic review of the literature and
recommendations for future research
Abstract
Background: Although the association between asthma and psychosocial factors has long been
recognised, it is only in the last decade that the impact of coexisting asthma and depression has become
the focus of considerable research interest. However, the findings so far have been confusing and often
contradictory. This paper sets out a methodical review and appraisal of the literature to date, including
suggestions for future research. Method: PubMed and PsycINFO databases were used to search for
English-language articles relating to asthma and depression research. The resulting articles were then
reviewed and summarised, creating a report that was used to develop research recommendations.
Results: The main findings from this review included: (a) results are mixed as to whether persons with
asthma are more likely to be depressed than those without asthma; (b) asthma and depression may have
an 'additive' adverse effect on the normal asthma-related quality of life reductions; (c) subjective
measures of asthma severity may be more strongly related to depression than objective measures; (d)
specific asthma symptoms appear to be linked to depression; (e) sadness and depression can produce
respiratory effects consistent with asthma exacerbations; (f) depression appears to be negatively related
to asthma treatment compliance; (g) corticosteroid use in asthma treatment has been associated with
depression, though it is unclear how common this problem is in real life; (h) interventions that address the
physical, psychological, and social consequences of asthma are likely to lead to the most successful
treatment outcomes; (i) treating the depression of individuals with asthma is likely to minimise the
negative effects of the coexistence; and (j) a number of common methodological problems were
observed in the literature. Recommendations: There is a large amount of research yet to be undertaken to
clarify issues around asthma and depression, with the overdue next step being to design integrated
treatment approaches, and carry out large-scale prospective studies to determine the impact of using
such approaches to treat individuals with depression and asthma. Such studies will be the only way in
which some fundamental questions about the development and coexistence of these two conditions will
be answered.
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Abstract
Background: Although the association between asthma and psychosocial factors has long been
recognised, it is only in the last decade that the impact of coexisting asthma and depression has
become the focus of considerable research interest. However, the findings so far have been
confusing and often contradictory. This paper sets out a methodical review and appraisal of the
literature to date, including suggestions for future research.
Method: PubMed and PsycINFO databases were used to search for English-language articles
relating to asthma and depression research. The resulting articles were then reviewed and
summarised, creating a report that was used to develop research recommendations.
Results: The main findings from this review included: (a) results are mixed as to whether persons
with asthma are more likely to be depressed than those without asthma; (b) asthma and depression
may have an 'additive' adverse effect on the normal asthma-related quality of life reductions; (c)
subjective measures of asthma severity may be more strongly related to depression than objective
measures; (d) specific asthma symptoms appear to be linked to depression; (e) sadness and
depression can produce respiratory effects consistent with asthma exacerbations; (f) depression
appears to be negatively related to asthma treatment compliance; (g) corticosteroid use in asthma
treatment has been associated with depression, though it is unclear how common this problem is
in real life; (h) interventions that address the physical, psychological, and social consequences of
asthma are likely to lead to the most successful treatment outcomes; (i) treating the depression of
individuals with asthma is likely to minimise the negative effects of the coexistence; and (j) a number
of common methodological problems were observed in the literature.
Recommendations: There is a large amount of research yet to be undertaken to clarify issues
around asthma and depression, with the overdue next step being to design integrated treatment
approaches, and carry out large-scale prospective studies to determine the impact of using such
approaches to treat individuals with depression and asthma. Such studies will be the only way in
which some fundamental questions about the development and coexistence of these two
conditions will be answered.
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Although the pathophysiology of asthma is clearly
defined, the psychological influences are currently less
well understood [1]. Depression is one of the most prevalent psychological problems in allergic patients [2],
though it is often regarded as a somewhat 'natural reaction' to the diagnosis of a significant illness such as
asthma [3-5]. However, while sadness and mild depression may be considered a fairly normal response to a diagnosis of chronic illness, more severe, chronic depression
can lead to serious consequences for persons with asthma
[4].

Research history
The association between asthma and psychological factors
has been recognised for centuries [6]. Asthma has long
been considered a psychosomatic disease, and during the
1930s–50s, was even known as one of the 'holy seven'
psychosomatic illnesses [7]. At that time, psychoanalytic
theories described the aetiology of asthma as psychological [8], with treatment often primarily involving psychoanalysis and other 'talking cures' [9]. As the asthmatic
wheeze was interpreted as the child's suppressed cry for
his or her mother, psychoanalysts viewed the treatment of
depression as especially important for individuals with
asthma [10].
During the early 1970s, as the understanding of the aetiology and pathophysiology of asthma improved [11,12],
the emphasis on psychological issues decreased. There
were, however, increases in asthma-related morbidity and
mortality in many first-world countries [13], which were
eventually attributed to the inappropriate use of β-agonists without corticosteroids. This issue led to a resurrection of psychosocial research relating to non-medical
factors in asthma, involving variables such as poor family
functioning, poor doctor-patient relationships, and social
difficulties [11]. In the 1980s–1990s the growing interest
in psychosocial variables also led to a number of studies
being conducted into the links between asthma and anxiety and variables such as 'negative affect' or 'psychological
distress', and in the late 1990s the connections between
asthma and depression came to the research forefront, as
the potential importance of this relationship came to be
recognised. Today, as a result of years of biopsychosocial
research, asthma is considered a disease of the pulmonary
system with genetic and allergic origins that is significantly affected by psychosocial factors.

Asthma, depression, and quality of life
It is well documented that individuals with asthma tend
to experience reduced health-related quality of life
(HRQOL) [14], and although HRQOL tends to be lower
for individuals with severe asthma, the effect on those
with more mild asthma can also be considerable [15,16].
Asthma of any severity may lead to reductions in each of
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the physical, psychological, and social domains of
HRQOL [17], with most people with asthma reporting
some restriction on their life and having poorer health status than individuals without asthma [17,18]. A large population-based study by Ford et al [14] demonstrated that
individuals with asthma had significantly lower HRQOL
than those who had never had asthma, and also experienced an average of 10 days per month of impaired physical or mental health, almost double that of those who
had never had asthma.
The Medical Outcomes Study demonstrated that depression and chronic disease often have 'additive' adverse
effects on wellbeing [19,20], and there is evidence to support this finding for asthma and depression. People with
coexisting asthma and depression have significantly lower
overall HRQOL, and also experience lower physical and
mental health functioning than those with similar asthma
activity but fewer depressive symptoms [21-23]. These
findings of reduced asthma-related quality of life are similar to those found in studies of other chronic medical
conditions, where a history of depression has also been
associated with poorer functional health status
[19,20,24,25].

Are people with asthma more likely to be
depressed?
Investigations of the prevalence of depression in asthma
have reported findings ranging from 1% to 45% of individuals with asthma also suffering from depression or
depressive symptoms [22,23,26-31]. Unfortunately, this
wide variation in the reported rates makes it difficult to
draw conclusions, but most authors suggest an increased
prevalence of depression in patients with asthma.
Various studies have investigated whether individuals
with asthma are more likely to be depressed than those
without asthma, and while a number of studies have supported this hypothesis [5,32-36], other investigators
[1,27] have not found such evidence. In response to the
differing findings in regards to this issue, Adams [37] theorised that differing sampling techniques may have been
related to the discrepancies between findings.

Asthma severity and depression
While it seems logical that having more severe asthma
would be associated with an increased risk of depression,
studies have reported somewhat mixed results. In investigations utilising objective measures of asthma severity
(i.e. clinician diagnoses, airway reactivity testing), Mrazek
[34] found that more severe asthma was associated with
increased depressive symptoms; however, studies by Afari
et al [21] and Janson et al [27] did not find this association. Thus, the evidence so far does not strongly support a
direct relationship between objective asthma severity and
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depression. However, two studies that used patients' subjective ratings of their own asthma severity found significant relationships between perceived asthma severity and
depressive symptoms [5,38].
Taken as a whole, these investigations seem to suggest that
subjective measures of asthma severity may be more
strongly related to depression than objective severity
measures. One potential explanation for this possibility is
that the individual's perception of their own asthma
severity may be more important than the 'real' severity of
the individual's asthma in determining whether or not
asthma leads to the person becoming depressed.

Specific asthma symptoms and depression
A small number of studies have investigated the links
between specific asthma symptoms and depression. One
of these, a population study by Goldney et al [39], examined the relationship between depression (as measured by
the Prime-MD) and a number of symptoms known to be
related to asthma severity, and found that dyspnoea, wakening at night, and morning symptoms were particularly
strongly associated with depression. Another study by Janson et al [27] found significant positive correlations
between depression (as determined by the Hospital Anxiety and Depression Scale (HADS)) and various, but not
all, symptoms of asthma.
However, while specific symptoms of asthma may be
linked to depression, it is also possible that the assessment
of depression in the afore-mentioned studies could have
been inaccurate due to the misinterpretation of asthma
symptoms as symptoms of depression. Alternatively, it is
possible that the findings and their interpretation are
accurate, and certain symptoms of asthma may be related
to depression due to their effect on the individual's quality
of life [39]. The finding of Goldney et al [39] relating
asthma symptoms to significant decrement in the quality
of life also leads to the question of whether experiencing
certain specific asthma symptoms might lead to person
with asthma becoming depressed, rather than depression
resulting from simply 'having' asthma.
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In the laboratory, Ritz et al [43] found increased total respiratory resistance in subjects with asthma (but not those
without asthma) following exposure to depressing stimuli. Krommydas et al [44] reported that individuals with
asthma and symptoms of depression (measured by the
Personal Disturbance Scale (DSSI/sAD)) had significantly
lower FEV1% than individuals with asthma who showed
no symptoms of depression. It is not clear from this study,
however, whether the results are due to the depression or
the depression is due to the reduced lung function.
Further, a study of overall physical vulnerability to asthma
by Miller and Wood [45] suggested that depressive emotions in children (evoked whilst viewing selected scenes
from the film 'ET: The Extra Terrestrial') may be associated
with greater cholinergic influence and instability of oxygen saturation, consistent with poorer airway function in
asthma. In contrast, happiness appeared to be related to
effects that were more likely to relieve airway constriction.
Ritz and Steptoe [40] conducted a study consisting of both
laboratory and field measurements, and demonstrated a
consistency between both situations. From the field measurements, episodes of strong positive and negative mood
were compared with records of relatively neutral emotional state, with the results showing that for persons with
asthma (but not those in the non-asthmatic control
group), negative affect, and to a lesser degree, positive
affect, were associated with a reduction in FEV1%. These
findings of reduced FEV1% during negative mood in the
'real life' component of the study were also consistent
with and significantly related to increases in respiratory
resistance during the viewing of a depressing film in the
study's laboratory component.
Overall, the research on affect and pulmonary function
indicates that depressed or sad mood, even when only
short-lived and mild, can produce respiratory effects that
are consistent with heightened airway vulnerability or
asthma exacerbations. Further investigations are needed
to establish whether this effect commonly occurs in the
everyday lives of persons with asthma.

Can depression have a direct effect on
pulmonary functioning?

Depression, asthma self-management, and
treatment compliance

The influence of emotional states on pulmonary function
in asthma has been studied extensively [40]. Recent findings indicate that airways are reactive to psychological
states, with these reactions causing changes consistent
with greater airway instability and asthma exacerbations
[41]. Consistent with this finding, personal retrospective
accounts of asthma exacerbations have also suggested that
changes in emotional states often result in asthma exacerbations [42].

Self-management of asthma can be challenging, due to
the often complicated and onerous nature of treatment
[41,46]. The individual with asthma may need to avoid
allergens; take preventive medication regularly; and
decide when reliever medications are required and
whether further medical assistance should be sought
[41,46]. Further, the potential implications of poor management and reduced compliance are serious, with consistently negative effects for individuals with asthma being
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reported, including increased morbidity [47] and mortality [48,49].
Depression, which has negative effects on cognitive functioning, energy, and motivation [41], has been identified
as one factor which may decrease the effectiveness of
asthma self-management and compliance. A meta-analysis by DiMatteo et al [50] revealed that patients with a
chronic disease and depression were three times more
likely to be noncompliant with medical treatment than
non-depressed patients. Bosley et al [51] found that individuals with asthma who were classified as 'noncompliant' (took less than 70% of their prescribed doses of
inhaled medication) had significantly higher depression
scores (measured on the HADS) than those who were
compliant, and Cluley and Cochrane [11] reported that in
their investigation of a group of 19 people with asthma
who had been diagnosed with depression (as assessed by
both the HADS and the Structured Clinical Interview for
the DSM-III-R Patient Edition (SCID-P)), only one was
adherent to their medication regime.
Depression might interfere with asthma treatment compliance and self-management via several pathways: firstly,
depression-related hopelessness may lead to a patient seeing little point in taking their medication as instructed
[52]; depression can also result in isolation from family
and friends who could offer the support that has often
been noted as important for compliance [52]; and finally,
depression may also be associated with declines in areas
of cognitive functioning (such as problem solving, complex task performance, concentration, attention span, and
memory) that are vital for compliance with treatment recommendations [37,53-55].
Unfortunately, the correlational studies mentioned here
cannot determine whether depression causes reduced
compliance or vice-versa, whether there are mediating factors in the relationship, or whether the relationship
between depression and compliance may be bi-directional [50]. DiMatteo et al [50] have also hypothesised the
possibility of a 'feedback loop', in which depression leads
to treatment non-compliance, non-compliance further
exacerbates asthma, asthma exacerbations lead to
increased depression, and so on, resulting in a cycle of
ever-worsening outcomes for the individual.

Corticosteroid use and depression
Corticosteroid use has also been hypothesised as a link
between asthma and depression [18,46,56]. The creation
of more potent inhaled corticosteroids (ICS), together
with more efficient delivery systems, has greatly increased
the use of ICS in the last 20 years [18]. While these
changes have had positive effects on overall health, they
have also been related to adverse side effects [57].
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Although early reports of a possible relationship between
asthma medications and depression were rare, and often
anecdotal, recent studies in this area seem to suggest a
stronger link than first believed. For example, an investigation by Patten and Lavorato [58] found that corticosteroid use was significantly associated with a 'syndrome
resembling major depression' (measured by the Composite International Diagnostic Interview Short-Form (CIDISF)), and in a study by Patten [59] of 73,402 community
members, it was found that among individuals taking corticosteroids (current or within the past month), the prevalence of major depression (11.1%; also measured by the
CIDI-SF) was significantly higher than for those who had
not taken steroids (4.1%). Perceived health status was not
a confounder in this study. In a smaller outpatient study
(N = 50), Bonala et al [18] found high-dose ICS usage was
associated with positive effects in relation to pulmonary
functioning and 'physical' quality of life, but was inversely
related to 'mental' quality of life.
There appear to be a number of gaps and problems in the
literature to date on ICS and depression in asthma. For
example, some studies seem to have overlooked the possibility that the illness for which the corticosteroid was
being taken may have been responsible for the increased
levels of depression, instead of the medication. Also, it is
unclear if depression related to corticosteroid use is actually a common problem. As mentioned, earlier accounts
of this relationship were infrequent, and it may be that as
ICS have become more potent and prescribed, the problem has increased exponentially. Another possible explanation for increased recognition of depression in persons
using ICS for asthma treatment may simply be that medical practitioners have become more adept in recognising
depression.

A 'feedback loop' of depression and asthma?
A number of researchers have suggested that a so-called
'feedback loop' may exist between asthma and depression
[42,45]. Lehrer et al [42] noted that negative emotion
(such as depression) often experienced by people with
asthma may be as much a result of having asthma, as it is
a cause of it, and that this bidirectional association may
lead to a continual cycle of asthma and depression, resulting in ever-worsening physical and mental health. DiMatteo et al [50] noted the possibility that non-compliance
with medical treatment might also be a component in this
cycle.

Clinical implications: a 'whole person' approach
to treatment
As discussed above, the coexistence of asthma and depression has been linked to a number of negative effects on
both the physical and mental health of the individual.
These adverse effects have led several researchers to pro-
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pose that the most successful treatment is likely to require
an integrated treatment approach, using interventions to
address the physical, psychological, and social consequences of asthma [45,60].
One suggested treatment combination has been to treat
depression and asthma together using antidepressants
with anticholinergic properties, such as tricyclic antidepressant medication [4,45,60]. However, some who have
advocated the use of antidepressant medications have also
warned that antidepressants alone may not be the entire
answer for a chronic disease such as asthma, because people with asthma need to be able to "successfully grieve
over physical losses, combat changes in self-esteem, and
overcome the social isolation that illness can cause" [[60],
p.296]. For these reasons, counselling and psychosocial
aspects in treatment are likely to have a very important
role in successful asthma treatment, and cognitive-behavioural therapy (CBT) and group and individual counselling are already being combined with asthma selfmanagement information to try to improve health outcomes for asthma sufferers [61].
It is hoped that by treating depression in asthma, the negative effects of this coexistence can be minimised [33,51].
While treating depression may increase adherence and
lead to more effective asthma self-management, decrease
asthma symptoms, and possibly even decrease asthmarelated mortality [11,44,61-63], at a minimum, treating
depression is likely to dramatically improve the HRQOL
of individuals with asthma [64].
To date, only one study is believed to have examined the
impact of treating depression in asthma. Grover et al [65]
recruited a sample of 10 asthma out-patients, with participants sequentially allotted to either the experimental
group (CBT and standard pharmacotherapy for asthma)
or control group (standard pharmacotherapy only). CBT
in the experimental group consisted of 15 individual sessions involving asthma education, muscle relaxation techniques, behavioural techniques, cognitive restructuring,
and coping skills. Following the full course of therapy and
medication, the experimental group had significant
decreases in asthma symptoms, anxiety, and depression
(measured by the Beck Depression Index), and a significant increase in quality of life, while the control group did
not show any significant changes. Although these results
are promising, further investigation into the effects of
employing combined treatment approaches is obviously
necessary.

Methodological issues in the literature
A number of problematic methodological issues were
observed in the studies examined in this review, many of
which limited interpretations of the findings. Firstly, the
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majority of the reviewed studies were cross-sectional and
retrospective in design, meaning that neither directionality nor causality could be reliably inferred from the results
[22,28,37,42,50,66]. Instead, many researchers hypothesised causality and relationship direction in their own
findings based on the conclusions of other studies.
The different measurement instruments used and names
given to the constructs of depression examined in the
studies, ('depression', 'depressive symptoms', 'major
depression', 'a syndrome resembling major depression',
etc) also made it difficult both to understand what was
actually being measured and investigated, and to compare
results and interpretations between studies. Comparatively few studies used standardised diagnostic instruments such as the DSM and SCID, or standardised clinical
rating scales such as the Hamilton Rating Scale for Depression, the consistent use of which would make interpretation and cross-study comparisons more straightforward.
The problems of unclear definitions of depression and
lack of standardised assessment measures were also noted
by Rodin and Voshart [cited in [67]] as issues hindering
progress on research in the medically ill.
Because asthma and depression share a number of symptoms, there is also potential for the use of self-report
measures in studies to result in inaccurate diagnoses of
depression or depressive symptoms [23,37,68]. Sherwood
Brown et al [23] noted that on some measures, secondary
symptoms of asthma such as decreased sleep or fatigue
may elevate scores on measures of depression, even if
these symptoms are actually unrelated to psychological
problems. This issue will require careful selection of
instruments to measure depression.
Finally, most samples utilised in studies investigating
asthma and depression have been drawn from in-patient
or outpatient samples, with very few population or primary care studies conducted thus far. Although these studies have been instrumental in highlighting links between
asthma and depression, the generalisability of these findings to the broader asthma population is not yet well
understood [39].

Future research directions
There are many potential research avenues to consider in
regards to the coexistence of asthma and depression.
Firstly, further investigation of the various links considered in this review (especially those explored in studies
that may have been limited by methodological issues)
would serve to provide a clearer understanding of the relationships between asthma and depression, and the potential repercussions of this association.
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Future research should also consider 'big picture' studies,
in which a number of different variables such as medication compliance, asthma self-management, quality of life,
and lung function might all be examined in one investigation. These studies are likely to be particularly vital in aiding our understanding of possible 'feedback loops' of
asthma and depression, more fully exploring how asthma
and depression coexist, and may be valuable in determining how best to reduce or eliminate the negative effects of
this coexistence.
Researchers have been suggesting for some time that the
most important next step in asthma and depression
research is to investigate the effects of treating the depression of persons with asthma. However, as previously mentioned, only one small study appears to have attempted
this so far [65]. The first step in this new research phase
would be to develop effective combinations of pharmacological, psychological, and/or psychosocial interventions
as an integrated treatment program for people with
asthma and depression. The most sought after knowledge,
however, would result from studies using these integrated
programs to actually treat the depression of individuals
with asthma, and assessing the effects of this treatment on
variables such as the depression itself, compliance, selfmanagement, HRQOL, pulmonary function, asthma
symptom exacerbations, overall asthma severity, and
asthma-related mortality. Large scale studies of this type
would be complex to set up, expensive to carry out, and
require long-term commitment to the research.
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